The Story
PT-141 (Bremelanotide) is a melanocortin receptor agonist that works through the central nervous system to enhance sexual desire and arousal — unlike PDE5 inhibitors which work peripherally. It is FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women and used off-label in men.
Description
PT-141 (Bremelanotide) is a melanocortin receptor agonist that works through the central nervous system to enhance sexual desire and arousal — unlike PDE5 inhibitors which work peripherally. It is FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women and used off-label in men.

















